Trial readiness: understanding the natural history of rare diseases

Inherited metabolic diseases (IMD) represent the largest and still growing group of treatable genetic disorders and are increasingly amenable to targeted interventions that achieve varying degrees of prognostic improvement. Innovative therapies are on the horizon and offer promising opportunities fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Opladen, Thomas (Author) , Mütze, Ulrike (Author) , Gleich, Florian (Author) , Garbade, Sven (Author) , Kuseyri Hübschmann, Oya (Author) , Zielonka, Matthias (Author) , Kölker, Stefan (Author)
Format: Article (Journal)
Language:English
Published: November 2025
In: Journal of inherited metabolic disease
Year: 2025, Volume: 48, Issue: 6, Pages: 1-10
ISSN:1573-2665
DOI:10.1002/jimd.70102
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/jimd.70102
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.70102
Get full text
Author Notes:Thomas Opladen, Ulrike Mütze, Florian Gleich, Sven F. Garbade, Oya Kuseyri Hübschmann, Matthias Zielonka, Stefan Kölker

MARC

LEADER 00000naa a2200000 c 4500
001 1943077118
003 DE-627
005 20251202094548.0
007 cr uuu---uuuuu
008 251202s2025 xx |||||o 00| ||eng c
024 7 |a 10.1002/jimd.70102  |2 doi 
035 |a (DE-627)1943077118 
035 |a (DE-599)KXP1943077118 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Opladen, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)124489656  |0 (DE-627)642820481  |0 (DE-576)335321291  |4 aut 
245 1 0 |a Trial readiness  |b understanding the natural history of rare diseases  |c Thomas Opladen, Ulrike Mütze, Florian Gleich, Sven F. Garbade, Oya Kuseyri Hübschmann, Matthias Zielonka, Stefan Kölker 
264 1 |c November 2025 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Zuerst veröffentlicht: 23. November 2025 
500 |a Gesehen am 02.12.2025 
520 |a Inherited metabolic diseases (IMD) represent the largest and still growing group of treatable genetic disorders and are increasingly amenable to targeted interventions that achieve varying degrees of prognostic improvement. Innovative therapies are on the horizon and offer promising opportunities for disease-changing treatment for a variety of IMDs. For the development of clinical trials specifically for IMDs and in the context of trial readiness, a thorough understanding of the natural history of the IMDs is indispensable for an objective evaluation of meaningful improvement of novel treatment options. Patient registries are key instruments in this regard, since they are recognized as powerful instruments for the collection of longitudinal real-world data, elucidating the phenotypic diversity of disease courses, understanding the impact of diagnosis and treatment on clinical outcomes, and investigating prognostic factors. At the same time, they enable the collection of patient-specific outcome parameters (PROMs) that improve the understanding of the natural phenotype in rare diseases by identifying clinically relevant endpoints, disease burden over time, unmet medical needs, and the impact of diseases and prescribed diets and medication on the quality of life of patients and caregivers. Meta-analysis and quantitative retrospective natural history modeling allow the evaluation of the disease course with the help of published aggregate data, where patient registries are not available. Finally, the various data sources provide the theoretical basis for practical applications such as the creation of consensus-based guidelines, pass studies, and mathematical modeling. This review describes the various options for evaluating and understanding the natural history of rare IMDs in detail, with the ultimate aim of achieving adequate trial readiness. 
700 1 |a Mütze, Ulrike  |d 1979-  |e VerfasserIn  |0 (DE-588)135567963  |0 (DE-627)693593024  |0 (DE-576)279666438  |4 aut 
700 1 |a Gleich, Florian  |e VerfasserIn  |0 (DE-588)1114740195  |0 (DE-627)86900445X  |0 (DE-576)47746100X  |4 aut 
700 1 |a Garbade, Sven  |d 1971-  |e VerfasserIn  |0 (DE-588)129234362  |0 (DE-627)707186889  |0 (DE-576)297554263  |4 aut 
700 1 |a Kuseyri Hübschmann, Oya  |d 1985-  |e VerfasserIn  |0 (DE-588)1038105617  |0 (DE-627)756673372  |0 (DE-576)392127156  |4 aut 
700 1 |a Zielonka, Matthias  |d 1983-  |e VerfasserIn  |0 (DE-588)1056891297  |0 (DE-627)79418670X  |0 (DE-576)412871637  |4 aut 
700 1 |a Kölker, Stefan  |e VerfasserIn  |0 (DE-588)1022937758  |0 (DE-627)717335771  |0 (DE-576)366197568  |4 aut 
773 0 8 |i Enthalten in  |t Journal of inherited metabolic disease  |d Hoboken, NJ : Wiley, 1978  |g 48(2025), 6 vom: Nov., Artikel-ID e70102, Seite 1-10  |h Online-Ressource  |w (DE-627)320457753  |w (DE-600)2006875-X  |w (DE-576)105704652  |x 1573-2665  |7 nnas  |a Trial readiness understanding the natural history of rare diseases 
773 1 8 |g volume:48  |g year:2025  |g number:6  |g month:11  |g elocationid:e70102  |g pages:1-10  |g extent:10  |a Trial readiness understanding the natural history of rare diseases 
856 4 0 |u https://doi.org/10.1002/jimd.70102  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.70102  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251202 
993 |a Article 
994 |a 2025 
998 |g 1022937758  |a Kölker, Stefan  |m 1022937758:Kölker, Stefan  |d 910000  |d 910500  |d 50000  |e 910000PK1022937758  |e 910500PK1022937758  |e 50000PK1022937758  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 7  |y j 
998 |g 1056891297  |a Zielonka, Matthias  |m 1056891297:Zielonka, Matthias  |d 910000  |d 910500  |d 50000  |e 910000PZ1056891297  |e 910500PZ1056891297  |e 50000PZ1056891297  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 6 
998 |g 1038105617  |a Kuseyri Hübschmann, Oya  |m 1038105617:Kuseyri Hübschmann, Oya  |d 910000  |d 910500  |e 910000PK1038105617  |e 910500PK1038105617  |k 0/910000/  |k 1/910000/910500/  |p 5 
998 |g 129234362  |a Garbade, Sven  |m 129234362:Garbade, Sven  |d 910000  |d 910500  |e 910000PG129234362  |e 910500PG129234362  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 1114740195  |a Gleich, Florian  |m 1114740195:Gleich, Florian  |d 50000  |e 50000PG1114740195  |k 0/50000/  |p 3 
998 |g 135567963  |a Mütze, Ulrike  |m 135567963:Mütze, Ulrike  |d 50000  |e 50000PM135567963  |k 0/50000/  |p 2 
998 |g 124489656  |a Opladen, Thomas  |m 124489656:Opladen, Thomas  |d 910000  |d 910500  |d 50000  |e 910000PO124489656  |e 910500PO124489656  |e 50000PO124489656  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1943077118  |e 481845124X 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1943077118","language":["eng"],"note":["Zuerst veröffentlicht: 23. November 2025","Gesehen am 02.12.2025"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"November 2025"}],"name":{"displayForm":["Thomas Opladen, Ulrike Mütze, Florian Gleich, Sven F. Garbade, Oya Kuseyri Hübschmann, Matthias Zielonka, Stefan Kölker"]},"id":{"doi":["10.1002/jimd.70102"],"eki":["1943077118"]},"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"relHost":[{"id":{"doi":["10.1002/(ISSN)1573-2665"],"eki":["320457753"],"issn":["1573-2665"],"zdb":["2006875-X"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of inherited metabolic disease","title_sort":"Journal of inherited metabolic disease","subtitle":"JIMD ; official journal of the Society for the Study of Inborn Errors of Metabolism"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Trial readiness understanding the natural history of rare diseasesJournal of inherited metabolic disease","titleAlt":[{"title":"JIMD"}],"part":{"year":"2025","text":"48(2025), 6 vom: Nov., Artikel-ID e70102, Seite 1-10","volume":"48","extent":"10","issue":"6","pages":"1-10"},"pubHistory":["1.1978 -"],"recId":"320457753","note":["Gesehen am 11.03.20","Ungezählte Beil.: Suppl"],"language":["eng"],"origin":[{"publisherPlace":"Hoboken, NJ ; Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1978","dateIssuedDisp":"1978-","publisher":"Wiley ; Kluwer ; Springer Science + Business Media B.V"}]}],"title":[{"title":"Trial readiness","title_sort":"Trial readiness","subtitle":"understanding the natural history of rare diseases"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Thomas","role":"aut","display":"Opladen, Thomas","family":"Opladen"},{"display":"Mütze, Ulrike","family":"Mütze","given":"Ulrike","role":"aut"},{"given":"Florian","role":"aut","display":"Gleich, Florian","family":"Gleich"},{"given":"Sven","role":"aut","display":"Garbade, Sven","family":"Garbade"},{"given":"Oya","role":"aut","display":"Kuseyri Hübschmann, Oya","family":"Kuseyri Hübschmann"},{"role":"aut","given":"Matthias","family":"Zielonka","display":"Zielonka, Matthias"},{"family":"Kölker","display":"Kölker, Stefan","role":"aut","given":"Stefan"}]} 
SRT |a OPLADENTHOTRIALREADI2025